HNSBF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Hansa Medical AB (HNSBF) Ownership - Who owns Hansa Medical AB?

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Scheelevagen 22

Phone

+46 46165670

Employees

159

Web

https://www.hansabiopharma.com

Details

Group

Domestic Stock Funds

Fundamentals

HNSBF

Capitalization

151M

P/E Ratio

N/A

Risk (Beta)

0.64

Dividend Yield

N/A

Total Cash

405M

Total Cash/Share

6.18

Total Debt

1.08B

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.27%

Revenue

171M

ROE

N/A

Book Value

-589.32M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-12.84

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

2.29

Current Revenue Per Employee

239533.33

Dividends Per Share - Security

N/A

EBITDA

-616.54M

Float

N/A

Float - Current

N/A

Gross Income Margin

58.29

Revenue To Assets

-88.72

Shares Held By Institutions

115M

Shares Outstanding - Current

65.6M

Total Liabilities

1.39B

Total Volume MTD

N/A

Value

-1

Gain YTD

0.000

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology